Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00867451 · ClinicalTrials.gov registry record · Phase 1

Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)

A Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
Phase 1
Development phase
8
Enrollment target

NCT00867451 is a Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00867451, a Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
Phase 1
Development phase
8 participants
Enrollment target

Study Summary

This study will test the efficacy of a systematic, multi-modal intervention protocol designed to improve sleep functioning and subsequent alleviation of daytime cognitive and behavioral difficulties among children diagnosed with ADHD. It is hypothesized that children receiving behavioral and (if necessary) pharmacologic interventions targeting sleep will display improvement on objective and subjective sleep measures, neuropsychological tests, and teacher-, and parent-ratings of ADHD behaviors.

Interventions

  • DRUG Melatonin
  • BEHAVIORAL Sleep Intervention

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2010-01
Est. Completion 2011-07
Phase Phase 1

What the Registry Record Tells You About NCT00867451

The ClinicalTrials.gov registry entry for NCT00867451 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Melatonin is the first listed.

NCT00867451 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00867451 about?

NCT00867451 is a clinical study titled "Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)". This study will test the efficacy of a systematic, multi-modal intervention protocol designed to improve sleep functioning and subsequent alleviation of daytime cognitive and behavioral difficulties among children diagnosed with ADHD. It is hypothesized that children receiving behavioral and (if nec...

What is the current status of trial NCT00867451?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2010-01. Estimated completion is 2011-07.

What interventions are being tested in trial NCT00867451?

The interventions under investigation include: Melatonin (DRUG), Sleep Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00867451?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.